http://rdf.ncbi.nlm.nih.gov/pubchem/reference/19940367

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 650
issn 0885-3185
1531-8257
issueIdentifier 4
pageRange 642-650
publicationName Movement disorders : official journal of the Movement Disorder Society
startingPage 642
bibliographicCitation Fox SH, Henry B, Hill MP, Peggs D, Crossman AR, Brotchie JM. Neural mechanisms underlying peak‐dose dyskinesia induced by levodopa and apomorphine are distinct: Evidence from the effects of the alpha2 adrenoceptor antagonist idazoxan. Movement Disorders. 2001 Jul;16(4):642–50. doi: 10.1002/mds.1148.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_72cccc78454821c6630f199471850dec
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f62307b41be93ebdf6be1849081b3d4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_734d7b3f512a1135f3c4753ee89fd888
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ec0fb13cc71a88033645d6f1a49a2b67
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bfae83754037420f56e96b4c958d447b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cb63ed8a04a1e34de530560dc3105aad
date 200107
identifier https://doi.org/10.1002/mds.1148
https://pubmed.ncbi.nlm.nih.gov/11481687
isPartOf https://portal.issn.org/resource/ISSN/0885-3185
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5937
https://portal.issn.org/resource/ISSN/1531-8257
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Neural mechanisms underlying peak‐dose dyskinesia induced by levodopa and apomorphine are distinct: Evidence from the effects of the alpha2 adrenoceptor antagonist idazoxan
discusses http://id.nlm.nih.gov/mesh/M0012434
http://id.nlm.nih.gov/mesh/M0023971
http://id.nlm.nih.gov/mesh/M0014964
http://id.nlm.nih.gov/mesh/M0001603
http://id.nlm.nih.gov/mesh/M0000493
http://id.nlm.nih.gov/mesh/M0028778
http://id.nlm.nih.gov/mesh/M0001494
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D001058Q000633
http://id.nlm.nih.gov/mesh/D000978Q000633
http://id.nlm.nih.gov/mesh/D019329Q000494
http://id.nlm.nih.gov/mesh/D000317Q000494
http://id.nlm.nih.gov/mesh/D004409Q000503
http://id.nlm.nih.gov/mesh/D007980Q000633
hasSubjectTerm http://id.nlm.nih.gov/mesh/D009638Q000378
http://id.nlm.nih.gov/mesh/D015632
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D009460Q000187
http://id.nlm.nih.gov/mesh/D002144
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D009474Q000187
http://id.nlm.nih.gov/mesh/D005917Q000187
http://id.nlm.nih.gov/mesh/D013378Q000187
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D004305
http://id.nlm.nih.gov/mesh/D003342Q000187
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6005
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1388
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54459
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439260
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10647
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8519
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10611

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID92729815
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129228530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129497604
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129228531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53788198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129544235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID104231720
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128934001
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128094556
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53790373

Total number of triples: 70.